1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0001, S0001, NCT00017147
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: UCCRC-9523, NCI-T98-0038, NCT00003766, T98-0038
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CWRU-1A96, NCI-T97-0021, NCT00004072, T97-0021
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-10227, UCCRC-T99-0088, NCI-T99-0088, NCT00005066
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-0059-00-1, DUMC-T98-0059, NCI-T98-0059, NCT00005081, T98-0059
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-10325, CWRU-1699, NCI-T99-0111, NCT00005961, T99-0111
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CWRU-1298, NCI-89, NCT00005981, 89
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-3318-01-12, NCI-5632, NCT00046878, 3318-01-12
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: PBTC-015, NCI-06-C-0089, NCI-P6692, NCT00275002
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: DUMC-5515-06-1R2, DUMC-5515-04-1R0, GP-DUMC-5515-06-1R2, NCT00362921
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-07-C-0052, AOI-NCI-07-C-0052, NCT00436436
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-7341, NCI-T94-0082C, T94-0082
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: CWRU-ICC-1994, NCI-T94-0022D, T94-0022, NCT00002604
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTC-9702, NCI-T96-0103, NCT00002971
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-1094-99-6R5, DUMC-929-97-6R3, DUMC-980-98-6R4, NCI-T94-0080, NCT00003348, T94-0080
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: CASE-CWRU-2Y97, NCI-T97-0060, NCT00003567, T97-0060, CASE-2Y97
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CASE-CWRU-6496, NCI-T97-0029, NCT00003613, T97-0029, CASE-6496
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9870, NCT00003765, P9870
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9803, JHOC-NABTT-9803, NCT00004892
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-00-C-0105I, NCI-237, 237, NCT00020150
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-1388-02-8R2, DUMC-1388-00-8, NCI-490, DUMC-1388-01-8R1, NCT00006474, 490
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: PBTC-009, NCT00045721
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: PBTC-005, NCT00052780
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-12999B, 6461, NCI-6461, NCT00086970
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Temporarily closed
Age: 5 to 30
Sponsor: Other
Protocol IDs: CCHMCEH003, NCT00272870
|
